Evidence map›Paper›PMID 38391483›Full record

ReviewGels (Basel, Switzerland)2024

Reasoning on Pore Terminology in 3D Bioprinting.

Alexander Trifonov, Ahmer Shehzad, Fariza Mukasheva, Muhammad Moazzam, Dana Akilbekova

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander TrifonovDepartment of Chemical and Materials Engineering, School of Engineering, Nazarbayev University, Astana 010000, Kazakhstan.
Ahmer ShehzadDepartment of Chemical and Materials Engineering, School of Engineering, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0003-1142-651X
Fariza MukashevaDepartment of Chemical and Materials Engineering, School of Engineering, Nazarbayev University, Astana 010000, Kazakhstan.
Muhammad MoazzamDepartment of Chemical and Materials Engineering, School of Engineering, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0009-0005-9320-2131
Dana AkilbekovaDepartment of Chemical and Materials Engineering, School of Engineering, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0003-3694-0355

Funding

Ministry of science and higher education Kazakhstan AP14869460
6 · The paper itself

Abstract

Terminology is pivotal for facilitating clear communication and minimizing ambiguity, especially in specialized fields such as chemistry. In materials science, a subset of chemistry, the term "pore" is traditionally linked to the International Union of Pure and Applied Chemistry (IUPAC) nomenclature, which categorizes pores into "micro", "meso", and "macro" based on size. However, applying this terminology in closely-related areas, such as 3D bioprinting, often leads to confusion owing to the lack of consensus on specific definitions and classifications tailored to each field. This review article critically examines the current use of pore terminology in the context of 3D bioprinting, highlighting the need for reassessment to avoid potential misunderstandings. We propose an alternative classification that aligns more closely with the specific requirements of bioprinting, suggesting a tentative size-based division of interconnected pores into 'parvo'-(d < 25 µm), 'medio'-(25 < d < 100 µm), and 'magno'-(d > 100 µm) pores, relying on the current understanding of the pore size role in tissue formation. The introduction of field-specific terminology for pore sizes in 3D bioprinting is essential to enhance the clarity and precision of research communication. This represents a step toward a more cohesive and specialized lexicon that aligns with the unique aspects of bioprinting and tissue engineering.

Indexed as

3D printinghydrogel pore nomenclaturehydrogel scaffoldporositytissue engineering

Identifiers

PMID38391483
PMCPMC10887720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.